These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5453153)

  • 21. [Clinical pharmacology of isoniazid].
    Sokolova GV; Ivleva AIa; Ziia AV; Zeliger LR; Suvorova VI
    Probl Tuberk; 1984 Sep; (9):55-60. PubMed ID: 6504886
    [No Abstract]   [Full Text] [Related]  

  • 22. [INH-H 3 diffusion in tubercular lesions. Histoautoradiographic study].
    Popescu I; Nicolae M
    Ftiziologia; 1971; 20(5):489-94. PubMed ID: 5153655
    [No Abstract]   [Full Text] [Related]  

  • 23. Slow and rapid inactivators of isoniazid among Greek patients.
    Farhat S; Jodanoglou J; Pallikaris G; Lyberatos K; Gardikas C; Hadjiidannou J
    Am Rev Respir Dis; 1973 Nov; 108(5):1242-3. PubMed ID: 4746586
    [No Abstract]   [Full Text] [Related]  

  • 24. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of complex chemotherapy of pulmonary tuberculosis using rapid intravenous injections of isoniazid].
    Kobeleva GV
    Probl Tuberk; 1983 Apr; (4):28-31. PubMed ID: 6866965
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of pulmonary tuberculosis with intermittent dosage of streptomycin and isoniazid].
    Kisielewicz J; Fafrowicz B; Jablonowski Z; Kociecka I; Turczynowski R
    Gruzlica; 1970; 38(7):719-22. PubMed ID: 5453681
    [No Abstract]   [Full Text] [Related]  

  • 28. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K; Nagai H; Kurashima A; Mori M; Katayama T
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
    Kislitsyna NA; Kotova NI
    Probl Tuberk; 1980 Aug; (8):63-5. PubMed ID: 7403052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].
    Zbants AN; Tsurkan VP; Mustiatsé NA; Kurochkin SIa; Ustiian AI
    Probl Tuberk; 1982 Dec; (12):45-8. PubMed ID: 7156122
    [No Abstract]   [Full Text] [Related]  

  • 31. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 32. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolism of isoniazid in humans. Reflexions of a practical nature].
    Fantoli U
    Lotta Tuberc; 1966; 36(7):231-45. PubMed ID: 5235940
    [No Abstract]   [Full Text] [Related]  

  • 34. [Optimization of indirect endolymphatic injection of isoniazid in pulmonary tuberculosis].
    Peleneva IM; Gariaeva NA; Burukhina LV; Zavgorodniĭ IG; Shurygin AA; Gorovits GA; Miroshnikova IP; Barlamov OP
    Probl Tuberk; 2002; (11):24-6. PubMed ID: 12501792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
    Aksüğür H; Gülbaran R; Cakirca R
    Poumon Coeur; 1967; 23(6):729-38. PubMed ID: 6070030
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
    Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
    Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.